Plasticell to collaborate with Pfizer, Cellzome and University of Sheffield in a £1.4 million Technology Strategy Board-funded stem cell project
Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced that the Technology Strategy Board has funded a research consortium comprising of Plasticell, Pfizer (Neusentis) and the University of Sheffield, led by Cellzome. The project will develop methods of characterizing stem cells through protein fingerprints predictive of changes in stem cell behaviour. The Technology [...]
Plasticell wins Technology Strategy Board funding for £1.5 million stem cell manufacturing project
Plasticell has announced that the Technology Strategy Board has made a further investment in the Company’s flagship technology, CombiCult™, the high throughput technology designed to solve the major bottleneck in stem cell research and development. The Technology Strategy Board will provide a grant of approximately £750k towards a £1.5 million project entitled ‘High Throughput Platform for the Discovery of GMP-Compatible [...]
Plasticell Delivers Differentiation Protocols to Stemnion, Inc.
Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the successful completion of a collaboration with Stemnion, Inc. (Pittsburgh, PA), a US biotechnology company focused on the applications of stem cells derived from human placentas. Plasticell used its flagship technology CombiCult™ to discover multiple novel, serum-free protocols that direct the differentiation of Stemnion’s [...]
Plasticell‘s CombiCult™ v2.0 platform wins international R&D 100 Award
Plasticell’s high throughput screen for stem cell differentiation joins list of the most significant technology products developed globally in the last 49 years Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has won the prestigious R&D 100 Award for its CombiCult™v2.0 system. The CombiCult™ platform is a high-throughput combinatorial screening technology that allows scientists [...]
Plasticell Spins Out Regenerative Drug Discovery Venture
New demerged business called ‘Progenitor Labs’ Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent £3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult™ technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery unit into a [...]
Plasticell completes £3.5 million financing round
Capital injection to expand business development and marketing initiatives Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced it has completed a two-part equity financing, raising a total of £3.5 million from new and existing investors. The first tranche of the financing, in which £1.5 million was drawn down in April 2009, was [...]
Plasticell signs technology agreement with Sigma-Aldrich
Collaboration to produce novel turnkey solution for stem cell research Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the signing of a collaboration agreement with Sigma-Aldrich, a leading provider of technologies and reagents to the life science research market. In the collaboration, Sigma-Aldrich will use its CompoZr® Zinc Finger Nuclease Technology to [...]
Plasticell signs screening collaboration with UCB. First in kind deal to partner small molecule drugs for stem cell research
Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB. Under the terms of the agreement, UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its award-winning CombiCult technology to discover new cell [...]
Plasticell validates regenerative drug screen in collaboration with GSK
London, 12 March 2009 … Research announced today by Plasticell, a leading UK regenerative medicine biotech company, shows how embryonic stem cells can be used to discover novel small molecules capable of encouraging the body to regenerate, potentially paving the way for the development of drugs to repair organs damaged by disease or ageing. Plasticell used its proprietary technologies to [...]
Plasticell funds two Industrial Collaborations with University College London
London, UK, 15 January 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, today announced that it is funding industrial collaborative projects in two separate laboratories based in University College London (UCL). The first collaboration, with the groups of Professors Chris Mason and Nigel Titchener-Hooker, of the UCL Advanced Centre for Biochemical Engineering, will result [...]
Plasticell obtains investment from TSB Technology Programme
London, UK, 1 October 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced it has received further funding from the Technology Strategy Board (TSB; formerly part of DTI) to apply its technologies towards developing a novel cell therapy designed to stimulate and sustain tissue regeneration. Plasticell is part of a consortium, additionally comprising [...]
Plasticell publication describes combinatorial methods in stem cell research
London, UK, 1 August 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the publication of a book chapter which presents the case for combinatorial methods in stem cell research. The chapter by Dr. Yen Choo, Plasticell’s founder, is entitled ‘Use of Combinatorial Screening to Discover Protocols That Effectively Direct the Differentiation of [...]
Plasticell appoints Professor Tony Cass to the Scientific Advisory Board
London, UK, 2 April 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has appointed Professor Tony Cass to its Scientific Advisory Board. Professor Cass is Professor of Chemical Biology, Deputy Director and Bio-nanotechnology Research Director in the Institute of Biomedical Engineering at Imperial College London. He is also a Founder and Executive Director of [...]
Plasticell acquires rights to two further human embryonic stem cell lines from King’s College London
London, UK, 13 February 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with King’s College London (London, UK) to exploit and market two human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source of human [...]
Plasticell acquires rights to six human embryonic stem cell lines
London, UK, 14 January 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Axordia Ltd (Sheffield, UK) to exploit and market a panel of six human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source [...]
Plasticell Chief Executive appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines
London, UK, 13 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that Dr Yen Choo, the company’s Chief Executive, has been appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines. Dr Choo is the first member of the Committee recruited from [...]